Month: February 2026

MIAMI, Feb. 11, 2026 (GLOBE NEWSWIRE) — Inter&Co Inc. (NASDAQ: INTR) the leading digital bank providing financial and commerce services to over 43 million customers, reported its financial results today for the fourth quarter of 2025. 2025 Highlights:Inter delivered another year of exceptional growth across key metrics, sustaining consistent profitability while accelerating market expansion.Client Growth: Added a record-breaking 4.4 million new active clients in 2025, bringing total active clients to 25 million. Credit Expansion: Expanded the credit portfolio by 36% year-over-year, more than three times the growth rate of the Brazilian market, driven by strategic products like Private Payroll Loans, Mortgages, and Credit Cards. Net Interest Margins (NIMs): Achieved record NIM and risk-adjusted NIM, increasing to 9.6% from...

KING OF PRUSSIA, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its fourth quarter and full year ended December 31, 2025. “In 2025, Vertex delivered double-digit revenue growth and meaningful profitability improvements while making important investments in the future,” said Christopher Young, President and Chief Executive Officer of Vertex. “We sustained our market position as the leading provider of indirect tax solutions to the enterprise and continued to onboard new customers at a healthy pace. In addition, our e-invoicing business enjoyed accelerating growth in its first full year, while setting the stage for upcoming mandates in key European economies.” Mr. Young continued, “Looking forward,...

RIDGEFIELD, Conn., Feb. 11, 2026 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today reported financial results for its fourth quarter ended December 26, 2025. Financial highlights for the fourth quarter of 2025:Net sales increased 10.5% to $1.14 billion for the fourth quarter of 2025 from $1.03 billion for the fourth quarter of 2024. GAAP net income was $21.7 million, or $0.50 per diluted share, for the fourth quarter of 2025 compared to $23.9 million, or $0.55 per diluted share, in the fourth quarter of 2024. Adjusted net income per share1 was $0.68 for the fourth quarter of 2025 compared to $0.55 for the fourth quarter of 2024. Adjusted EBITDA1 was $80.3 million for the fourth quarter...

Achieved Fourth-Quarter and Full-Year Records for Aggregates Revenues, Gross Profit and Margin Double-Digit Improvement in Full-Year Aggregates Unit Profitability Specialties Business Delivers Record Fourth-Quarter and Full-Year Revenues and Gross Profit Company Provides 2026 Guidance RALEIGH, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) — Martin Marietta Materials, Inc. (NYSE: MLM) (“Martin Marietta” or the “Company”), a leading national supplier of aggregates and heavy building materials, today reported results for the fourth quarter and year ended December 31, 2025. Fourth-Quarter and Full-Year Highlights(Financial highlights are for continuing operations, unless otherwise noted)  Quarter Ended December 31,   Year Ended December 31,(in millions, unless otherwise noted) 2025   2024 % Change   2025   2024 % ChangeRevenues2 $ 1,534     $ 1,412   9 %   $ 6,150     $ 5,662   9 %Gross...

— Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— –Company to host conference call and webcast today at 8:00 a.m. ET– MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. “The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for patients to ONLY lose fat, while preserving lean mass and physical function and increasing bone mineral density for the highest quality...

Q4 2025 Financial Highlights Q4 revenue of $1.6 billion decreased 8% year-over-year and 10% on an organic basis Total revenue growth of 11% and 8% on an organic basis excluding confidential contract Net income of $56 million increased 3% year-over-year, a fourth quarter record Record adjusted EBITDA of $153 million increased 5%; adjusted EBITDA margin of 9.6% Cash flow from operations increased 32% to $168 million Book-to-bill ratio of 0.9x and continued streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since IPOFiscal Year 2025 HighlightsFY25 revenue of $6.4 billion, decreased 6% year-over-year and 9% on an organic basis Total revenue growth of 12% and 8% on an organic basis excluding confidential contract Record net income of $241 million increased 3% Adjusted EBITDA of $609 million increased 1%; adjusted EBITDA...

Announces Board of Director Changes TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) — (TSX: CGX) – Today, Cineplex Inc. (“Cineplex” or the “Company”) released its financial results for the three months and year ended December 31, 2025. Unless otherwise specified, all amounts contained in this news release are in Canadian dollars. 2025 Highlights:Generated $91.6 million in Adjusted EBITDAaL compared to $89.9 million in the prior year Reported net loss of $36.9 million, an improvement of $67.3 million relative to the prior year net loss of $104.2 million Set annual records for Box Office Per Patron (“BPP”) at $13.29 and Concession Per Patron (“CPP”) at $9.72 International film product contributed 11.2% of total box office revenues, the highest share in Cineplex’s history Premium experiences accounted for 43.2% of total box office...